Hennion & Walsh Asset Management, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 237,499 shares of RCKT stock, worth $2.14 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
237,499
Previous 221,046
7.44%
Holding current value
$2.14 Million
Previous $4.08 Million
26.87%
% of portfolio
0.14%
Previous 0.2%
Shares
11 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$159 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$126 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$59.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$55.7 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$46.7 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $680M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...